Citation 88152

MATSUDA,H: MORIKAWA,T: NINOMIOYA,K: YOSHIKAWA,M:. (2001). ABSOLUTE STEREOSTRUCTURE OF CARABRANE-TYPE SESQUITERPENE AND VASORELAXANT-ACTIVE SESQUITERPENES FROM ZEDOARIAE RHIZOMA.. 57(40)

Citation Details

Title	ABSOLUTE STEREOSTRUCTURE OF CARABRANE-TYPE SESQUITERPENE AND VASORELAXANT-ACTIVE SESQUITERPENES FROM ZEDOARIAE RHIZOMA.
Authors	MATSUDA,H: MORIKAWA,T: NINOMIOYA,K: YOSHIKAWA,M:
Year	2001
Volume	57
Issue	40

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (2)

Curcuma zedoaria (ZINGIBERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	CURCUMENONE	None
2	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENONE	INACTIVE
3	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENONE	INACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CURCUMENONE,4(S)-DIHYDRO:	None
5	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENONE,4(S)-DIHYDRO:	ACTIVE
6	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENONE,4(S)-DIHYDRO:	INACTIVE
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CURCARABRANOL A	None
8	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCARABRANOL A	ACTIVE
9	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCARABRANOL A	INACTIVE
10	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CURCARABRANOL B	None
11	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCARABRANOL B	ACTIVE
12	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCARABRANOL B	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOLACTONE A	ACTIVE
2	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOLACTONE A	INACTIVE
3	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOLACTONE B	ACTIVE
4	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOLACTONE B	INACTIVE
5	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOLACTONE C	INACTIVE
6	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOLACTONE C	INACTIVE
7	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FURANODIENE	ACTIVE
8	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FURANODIENE	INACTIVE
9	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDERONE	ACTIVE
10	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDERONE	INACTIVE
11	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRONE	ACTIVE
12	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRONE	INACTIVE
13	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRONE,13-HYDROXY:	ACTIVE
14	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRONE,13-HYDROXY:	INACTIVE
15	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLECHOMANOLIDE	ACTIVE
16	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLECHOMANOLIDE	INACTIVE
17	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRONE-4-5-EPOXIDE,(+):	ACTIVE
18	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GERMACRONE-4-5-EPOXIDE,(+):	INACTIVE
19	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURDIONE	ACTIVE
20	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURDIONE	INACTIVE
21	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURDIONE,NEO:	ACTIVE
22	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURDIONE,NEO:	INACTIVE
23	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURDIONE,DEHYDRO:	ACTIVE
24	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURDIONE,DEHYDRO:	INACTIVE
25	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL	ACTIVE
26	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL	INACTIVE
27	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,4-EPI:	ACTIVE
28	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,4-EPI:	INACTIVE
29	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,ISO:	ACTIVE
30	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,ISO:	INACTIVE
31	Not specified	ISOLATION AND IDENTIFICATION OF	CURCUMENOL,NEO:	None
32	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,NEO:	ACTIVE
33	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,NEO:	INACTIVE
34	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,PRO:	ACTIVE
35	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,PRO:	INACTIVE
36	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,ISO-PRO:	ACTIVE
37	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMENOL,ISO-PRO:	INACTIVE
38	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMOXIDE	ACTIVE
39	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALISMOXIDE	INACTIVE
40	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIA-9-EN-8-ONE,7-ALPHA-11-ALPHA-EPOXY-5-BETA-HYDROXY:	ACTIVE
41	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIA-9-EN-8-ONE,7-ALPHA-11-ALPHA-EPOXY-5-BETA-HYDROXY:	INACTIVE
42	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AERUGIDIOL	INACTIVE
43	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AERUGIDIOL	INACTIVE
44	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOARONDIOL	ACTIVE
45	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOARONDIOL	INACTIVE
46	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOARONDIOL,ISO:	INACTIVE
47	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOARONDIOL,ISO:	INACTIVE
48	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOALACTONE B	ACTIVE
49	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOALACTONE B	INACTIVE
50	Not specified	ISOLATION AND IDENTIFICATION OF	ZEDOAROLIDE A	None
51	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOAROLIDE A	ACTIVE
52	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOAROLIDE A	INACTIVE
53	Not specified	ISOLATION AND IDENTIFICATION OF	ZEDOAROLIDE B	None
54	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOAROLIDE B	INACTIVE
55	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ZEDOAROLIDE B	INACTIVE
56	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TURMERONE,AR: (+):	ACTIVE
57	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TURMERONE,AR: (+):	INACTIVE
58	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISACUMOL	ACTIVE
59	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISACUMOL	INACTIVE
60	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISACURONE	INACTIVE
61	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISACURONE	INACTIVE
62	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMOL,BETA:	ACTIVE
63	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMOL,BETA:	INACTIVE
64	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DICTYOPTEROL,BETA:	ACTIVE
65	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DICTYOPTEROL,BETA:	INACTIVE
66	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURZERENONE	ACTIVE
67	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURZERENONE	INACTIVE
68	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMADIONE	ACTIVE
69	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMADIONE	INACTIVE
70	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
71	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	INACTIVE
72	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	METHANE,BIS(4-HYDROXY-CINNAMOYL):	ACTIVE
73	VASOCONSTRICTION INHIBITION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	METHANE,BIS(4-HYDROXY-CINNAMOYL):	INACTIVE